Home
>
US Stocks
>
Sensei Biotherapeutics Inc
Sensei Biotherapeutics Inc
SNSE

Sensei Biotherapeutics Inc

$7.1322.16%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
7.55
Today Low/High
7.13 / 7.55
52 Week Low/High
$6.74 / $26.5
Market Cap
$244.71M

Company Details

Sensei Biotherapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company has developed a proprietary bacteriophage-based platform, ImmunoPhage™, that enables the rapid generation of immune activating therapeutic agents that fully engage the immune system. Using the ImmunoPhage™ platform, Sensei is developing a library of ImmunoPhage, called Phortress™, to target multiple tumor-associated antigens to create a personalized yet off-the-shelf cocktail approach for treating cancer patients. The platform enables efficient, scalable and cost-effective manufacturing to support all of Sensei’s clinical programs. The company’s most advanced immunotherapy, SNS-301, a first-in-class ImmunoPhage™ targeting the tumor antigen Aspartyl beta Hydroxylase (ASPH), is currently in a Phase 1/2 clinical trial in patients with advanced Squamous Cell Carcinoma of the Head and Neck. Earlier stage programs include SNS-401, a ImmunoPhage™ cocktail for the treatment of Merkel Cell Carcinoma, and SNS-VISTA, an antibody-based therapeutic targeting an immune checkpoint gene that inhibits anti-tumor immune responses called V-domain Ig suppressor of T cell activation (VISTA).
Organisation
Sensei Biotherapeutics Inc
Employees
31

Discover more

Frequently Asked Questions

What is Sensei Biotherapeutics Inc share price today

Can Indians buy Sensei Biotherapeutics Inc shares?

How can I buy Sensei Biotherapeutics Inc shares from India?

Can Fractional shares of Sensei Biotherapeutics Inc be purchased?

What are the documents required to start investing in Sensei Biotherapeutics Inc stocks?

We are a SEBI registered investement advisor